These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 34935104)

  • 1. Effect on maximal mouth opening in children with spinal muscular atrophy treated with onasemnogene abeparvovec.
    Beri N; Kapoor L; Parashar D; Mundada V
    Arch Dis Child; 2023 Oct; 108(10):866-867. PubMed ID: 37553206
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination molecular therapies for spinal muscular atrophy: How much is enough?
    Mathews KD; Iannaccone ST
    Muscle Nerve; 2021 Mar; 63(3):279-281. PubMed ID: 33118639
    [No Abstract]   [Full Text] [Related]  

  • 3. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy.
    Baranello G;
    Eur J Paediatr Neurol; 2024 Jan; 48():67-68. PubMed ID: 38043384
    [No Abstract]   [Full Text] [Related]  

  • 4. Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven?
    Fontanelli L; Di Rauso G; Bellini G
    Eur J Neurol; 2024 Feb; 31(2):e16103. PubMed ID: 37877676
    [No Abstract]   [Full Text] [Related]  

  • 5. Living with spinal muscular atrophy while working in critical care.
    Wehner L; Malhotra A; Orr J
    Lancet Respir Med; 2024 Jul; 12(7):510-512. PubMed ID: 38851195
    [No Abstract]   [Full Text] [Related]  

  • 6. A Paradigm Shift for the Management of Critically Ill Patients With Spinal Muscular Atrophy.
    Bach JR; Palmieri JL
    Respir Care; 2023 Oct; 68(10):1481-1482. PubMed ID: 37722737
    [No Abstract]   [Full Text] [Related]  

  • 7. Spinal muscular atrophy - insights and challenges in the treatment era.
    Mercuri E; Pera MC; Scoto M; Finkel R; Muntoni F
    Nat Rev Neurol; 2020 Dec; 16(12):706-715. PubMed ID: 33057172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeo and Darras: Extraneuronal Phenotypes of Spinal Muscular Atrophy.
    Yeo CJJ; Darras BT
    Ann Neurol; 2021 Jan; 89(1):24-26. PubMed ID: 33051879
    [No Abstract]   [Full Text] [Related]  

  • 9. Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain.
    Skedgel C
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):3-5. PubMed ID: 34935104
    [No Abstract]   [Full Text] [Related]  

  • 10. Spinal muscular atrophy - the dawning of a new era.
    Farrar MA; Kiernan MC
    Nat Rev Neurol; 2020 Nov; 16(11):593-594. PubMed ID: 32978515
    [No Abstract]   [Full Text] [Related]  

  • 11. [Expert consensus on rehabilitation management of the spinal muscular atrophy].
    ;
    Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):883-887. PubMed ID: 36038296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of spinal muscular atrophy in European countries: A call to action.
    Vázquez-Costa JF; Martínez-Moreno M; Madruga-Garrido M; Munell F; Nascimento A; Pitarch-Castellano I; Pascual-Pascual SI; Povedano M; Cattinari MG
    Eur J Neurol; 2022 Nov; 29(11):3475-3477. PubMed ID: 35971869
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy for spinal muscular atrophy: hope and caution.
    Goemans N
    Lancet Neurol; 2021 Apr; 20(4):251-252. PubMed ID: 33743228
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective.
    Oskoui M; Gonorazky H; McMillan HJ; Dowling JJ; Amin R; Gagnon C; Selby K
    Can J Neurol Sci; 2022 May; 49(3):398-401. PubMed ID: 34082851
    [No Abstract]   [Full Text] [Related]  

  • 15. Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers.
    Sutherland CS; Hudson P; Mitchell S; Paracha N
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):39-67. PubMed ID: 34907515
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.